Nothing Special   »   [go: up one dir, main page]

DE60233338D1 - Verbesserte substratabbildung durch reversible bindung an einen paramagnetischen komplex - Google Patents

Verbesserte substratabbildung durch reversible bindung an einen paramagnetischen komplex

Info

Publication number
DE60233338D1
DE60233338D1 DE60233338T DE60233338T DE60233338D1 DE 60233338 D1 DE60233338 D1 DE 60233338D1 DE 60233338 T DE60233338 T DE 60233338T DE 60233338 T DE60233338 T DE 60233338T DE 60233338 D1 DE60233338 D1 DE 60233338D1
Authority
DE
Germany
Prior art keywords
reversible binding
substrate formation
improved substrate
paramagnetic complex
paramagnetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60233338T
Other languages
English (en)
Inventor
Enzo Terreno
Silvio Aime
Mauro Botta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco Imaging SpA
Original Assignee
Bracco Imaging SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging SpA filed Critical Bracco Imaging SpA
Application granted granted Critical
Publication of DE60233338D1 publication Critical patent/DE60233338D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DE60233338T 2001-10-11 2002-10-09 Verbesserte substratabbildung durch reversible bindung an einen paramagnetischen komplex Expired - Lifetime DE60233338D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01124440A EP1302465A1 (de) 2001-10-11 2001-10-11 Verbesserte MRI-Bildgebung mittels umkehrbares binding zu einem paramagnetischen Komplex
PCT/EP2002/011271 WO2003033479A1 (en) 2001-10-11 2002-10-09 Enhanced substrate imaging by reversible binding to a paramagnetic complex

Publications (1)

Publication Number Publication Date
DE60233338D1 true DE60233338D1 (de) 2009-09-24

Family

ID=8178947

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233338T Expired - Lifetime DE60233338D1 (de) 2001-10-11 2002-10-09 Verbesserte substratabbildung durch reversible bindung an einen paramagnetischen komplex

Country Status (6)

Country Link
US (1) US7608249B2 (de)
EP (2) EP1302465A1 (de)
JP (1) JP4817600B2 (de)
AT (1) ATE439350T1 (de)
DE (1) DE60233338D1 (de)
WO (1) WO2003033479A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1331012A1 (de) 2002-01-29 2003-07-30 BRACCO IMAGING S.p.A. Magnetisch beeinflussbare paramagnetische Kontrastmittel für Magnetresonanzbildgebung
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
EP1716870A1 (de) 2005-04-29 2006-11-02 Bracco Imaging S.p.A. Kontrastmittel für Kernspintomographie mit konzentrationsunabhängiger Empfanglichkeit
EP2051739A2 (de) * 2006-08-18 2009-04-29 GE Healthcare AS Bildgebungsmedium mit laktat und hyperpolarisiertem 13c-pyruvat
US8431552B2 (en) 2007-01-16 2013-04-30 Chien-Hung Chen Composition for treating metabolic syndrome
CA2666036C (en) 2008-05-16 2017-09-12 Chien-Hung Chen Novel compositions and methods for treating hyperproliferative diseases
WO2010056590A2 (en) * 2008-11-14 2010-05-20 University Of Maryland, Baltimore Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging
WO2011024156A1 (en) * 2009-08-31 2011-03-03 Brain Watch Ltd. Isotopically labeled neurochemical agents and uses thereof for diagnosing conditions and disorders
FR3025317B1 (fr) * 2014-08-26 2022-09-23 Imabiotech Methode de caracterisation d'un echantillon par imagerie par spectrometrie de masse

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US4933441A (en) * 1987-01-27 1990-06-12 Gibby Wendell A Contrast enhancing agents for magnetic resonance images
US5756065A (en) * 1988-06-24 1998-05-26 The Dow Chemical Company Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
US5597548A (en) * 1990-07-18 1997-01-28 Board Of Regents, The University Of Texas System 13 C Isotopomer analyses in intact tissue using (13 C) homonuclear decoupling
FR2725449B1 (fr) * 1994-10-05 1996-12-27 Air Liquide Derives de polyazacycloalcanes, leurs complexes metalliques et produits pharmaceutiques incorporant ces complexes
IT1293778B1 (it) * 1997-07-25 1999-03-10 Bracco Spa 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli
CA2249173C (en) * 1997-10-06 2008-12-16 Tokyo Gas Co., Ltd. Diagnostic agent for liver function
IT1304501B1 (it) * 1998-12-23 2001-03-19 Bracco Spa Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza
FR2802928B1 (fr) * 1999-12-22 2003-01-31 Air Liquide Polyazacycloalcanes eventuellement greffes sur une matrice solide, complexes organometalliques les incorporant comme ligands. utilisation desdits composes a l'extraction de metaux lourds

Also Published As

Publication number Publication date
ATE439350T1 (de) 2009-08-15
EP1434768B1 (de) 2009-08-12
JP2005508965A (ja) 2005-04-07
US20040258618A1 (en) 2004-12-23
JP4817600B2 (ja) 2011-11-16
US7608249B2 (en) 2009-10-27
EP1302465A1 (de) 2003-04-16
EP1434768A1 (de) 2004-07-07
WO2003033479A1 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
DE602005014248D1 (de) 1,4-bis(carboxymethyl)-6-äbis(carboxymethyl)aminoü-6-methyl-perhydro-1,4-diazepin (aazta)-derivate als liganden in kontrastmitteln mit hoher relaxivität zur verwendung bei der magnetresonanztomographie (mrt)
DE60233338D1 (de) Verbesserte substratabbildung durch reversible bindung an einen paramagnetischen komplex
WO2001082976A3 (en) Functional mri agents for cancer imaging
IL156949A (en) Method of synthesizing camptothecin-related compounds
ATE539060T1 (de) Styrylpyridinderivate und ihre verwendung zur bindung und abbildung von amyloider plaque
DE60115136D1 (de) Herstellung von dreidimensionalen Gegenständen durch kontrollierte Photohärtung
TW200721203A (en) Oxide magnetic material and method for producing the same, ferrite sintering magnet and method for producing the same
DE60326510D1 (de) Mehrkanal-Spulen-Netz zur BIlderzeugung des Herzens durch Kernspintomographie mittels Kodierung der Empfindlichkeit
BRPI0417543A (pt) quinolinas úteis no tratamento de doença cardiovascular
DE60227594D1 (de) Automatische Selektion von MR-Empfangsspulen durch Datenanalyse eines schnellen Vorscans
MX2008014898A (es) Composicion para el diagnostico de enfermedades relacionadas con amiloides.
ATE294813T1 (de) Konjugate von gallensäure mit metallbindenden chelatverbdingungen und die verwendung davon
DE60230561D1 (de) Supraleitender Magnet für die bildgebende magnetische Resonanz
CY1109740T1 (el) Νεα μεθοδος συνθεσης παραγωγων της 1,3,4,5 -τετραϋδρο-2η- 3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης της σε ενα φαρμακευτικως αποδεκτο οξυ
DE112006000984A5 (de) Verfahren zur Herstellung von 2,5-substituierten Tetrahydropyran-Derivaten durch reduktive Eliminierung des entsprechenden 4-Halogen-Derivats
NO20004561D0 (no) Metode for magnetisk resonansavbildning
CY1107101T1 (el) Μεθοδος συνθεσης παραγωγων της 1,3-διϋδρο-2h-3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης με φαρμακευτικως αποδεκτο οξυ
AU2003234183A8 (en) Novel macrocyclic activatible magnetic resonance imaging contrast agents
DE69503055D1 (de) Makrozyclische chelante, ihre chelate und verwendungen in diagnostik
DE60311309D1 (de) Durch oxidation vorbehandelter keramikleiter für eine zinkanode
EP1771732A4 (de) Taxol-immunoassay
WO2005122891A8 (en) Lipophilic derivatives of chelate monoamides
EA200800948A1 (ru) Биотиндиаминопроизводные и их конъюгаты с макроциклическими хелатирующими реагентами
DE60239859D1 (de) Verfahren zur photonenerzeugung durch sonolumineszenz
WO2004037210A3 (en) Functional mri agents for cancer imaging

Legal Events

Date Code Title Description
8364 No opposition during term of opposition